SEC Tracker
Get the app
SYK · XBRL financial data

Stryker financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SYK's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue5,8155,2435,4225,4946,4365,8666,0226,0577,1716,0206,5896,520
Cost of revenue2,112*1,9102,0061,9772,262*2,1222,1812,2052,543*2,2102,0912,272
Gross profit3,7033,3333,4163,5174,1743,7443,8413,8524,6283,8104,4984,248
Research and development350*368363377358*405407410401*413434433
Selling, general and administrative1,941*1,8401,8471,8962,102*2,3002,0792,0452,227*2,2812,2292,313
Total operating expenses2,446*2,3612,3652,4323,593*2,9072,7282,7172,824*2,8742,8393,214
Operating income (loss)1,257*9721,0511,085581*8371,1131,1351,804*9361,6591,034
Interest expenseyear only—9698104*137159157154*148141143
Income tax expense (benefit)83*135173209(18)*110132170856*105288244
Net income (loss)1,1437888258345466548848598497451,276753
Earnings per share, basic USD per share3.012.072.172.181.431.712.322.252.211.953.321.97
Earnings per share, diluted USD per share2.982.052.142.161.411.692.292.222.201.933.301.96
Weighted average shares, basic millions of shares380*380381381381*382382382382*383384382
Weighted average shares, diluted millions of shares384*385385386386*386386387386*387386385

Balance sheet

CSV

Fiscal quarters (SYK's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents2,9712,3301,8743,8503,6522,3202,3753,2564,0112,8783,3913,271
Marketable securities82778384918989878987850
Accounts receivable3,7653,4733,6223,7363,9873,9613,9183,6434,0393,5713,7433,693
Inventory4,8435,0265,0445,2924,7745,1055,2895,3705,3105,4195,5215,747
Total current assets12,51811,89211,64514,67314,84713,02213,00313,71114,75513,33814,41814,183
Property and equipment, net3,2153,2603,3183,4293,4483,5363,7023,7343,8763,8873,9584,054
Right-of-use asset494525510516516570551539519529521518
Goodwill15,24315,35115,40816,39615,85519,08919,18319,25619,29119,18819,58419,326
Total assets39,91239,40239,13043,83342,97146,00646,33147,05747,84446,29147,93047,247
Commercial paper000000000—250250
Total current liabilities7,9216,9556,9267,6697,6167,9297,2887,4147,7946,3156,6846,500
Long-term debt10,90110,80710,12713,32512,18814,38314,82914,84514,85914,22414,19214,176
Lease liability, non-current356378379374379414389377348350345343
Total liabilities21,31920,23019,36823,68422,33725,07625,14025,27225,42423,31223,94223,790
Retained earnings16,77117,25417,77418,30318,52818,86219,42319,96020,47220,87821,81521,248
Total liabilities and equity39,91239,40239,13043,83342,97146,00646,33147,05747,84446,29147,93047,247
Common shares outstanding (cover page) millions of shares380381381381382382382382383383384381

Cash flows

CSV

Fiscal quarters (SYK's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)1,1437888258345466548848598497451,276753
Stock-based compensation40*8746*51*45*8449*62*48*8754*67*
Depreciation and amortizationyear only355354371346*361389404416*397404397
Net cash from operating activities1,528*204633*1,474*1,931*2501,111*1,540*2,143*5811,261*1,461*
Purchases of property and equipment145*167152*170*266*123183*187*268*166202*237*
Net cash from investing activities(152)*(408)(117)*(2,172)*(303)*(4,136)(104)*(321)*(305)*(185)(639)*(187)*
Dividends paid285*304305*305*305*320321*322*321*337337*338*
Proceeds from long-term debt1,241*00*3,011*0*2,9790*0*0*00*0*
Repayments of long-term debt1,206*0600*1*1,438*0650*0*750*1,0000*0*
Net cash from financing activities(286)*(418)(966)*2,653*(1,794)*2,534(989)*(339)*(1,093)*(1,510)(95)*(1,393)*
Net change in cash1,111*(641)(456)*1,976*(198)*(1,332)55*881*755*(1,133)513*(120)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Stryker3,2716,5201,461*380.7M 10-QSep 30, 2026
Boston Scientific6095,1381,048*1.4B 10-QSep 30, 2026
Medtronic1,6919,7561,7931.3B 10-QJul 31, 2026
Intuitive Surgical2,9783,0491,224*346.6M 10-QSep 30, 2026
3M4,8356,584486*516.7M 10-QSep 30, 2026
Becton Dickinson7084,983not reported272.4M 10-QJun 30, 2026
Edwards Lifesciences2,9071,741652*576.4M 10-QJun 30, 2026
Resmed1,0111,415422140.7M 10-QSep 30, 2026
Dexcom9611,345326*373.0M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.